NCT00201526 Bipolar Research And Innovation Network - BRAIN
| NCT ID | NCT00201526 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Norwegian University of Science and Technology |
| Condition | Bipolar Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2003-01 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2003-01 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To describe the broad spectrum of Bipolar Disorder patients admitted to out-patient and in-patient psychiatric departments in Norway. Include all admitted Bipolar patients both with and without co-morbid disorders.
Eligibility Criteria
Inclusion Criteria: * All admitted patients giving written consent to participate in the study Exclusion Criteria: * Patients without competence for consent.
Contact & Investigator
Gunnar Morken, PhD MD
PRINCIPAL INVESTIGATOR
Norwegian University of Science and Technology
Frequently Asked Questions
Who can join the NCT00201526 clinical trial?
This trial is open to participants of all sexes, studying Bipolar Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00201526 currently recruiting?
Yes, NCT00201526 is actively recruiting participants. Contact the research team at arne.e.vaaler@ntnu.no for enrollment information.
Where is the NCT00201526 trial being conducted?
This trial is being conducted at Trondheim, Norway.
Who is sponsoring the NCT00201526 clinical trial?
NCT00201526 is sponsored by Norwegian University of Science and Technology. The principal investigator is Gunnar Morken, PhD MD at Norwegian University of Science and Technology. The trial plans to enroll 3,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.